ConductScience.org, home

Paper8701285

Fighting cancer by attacking its blood supply.

Folkman J. Sci Am, 1996. Cited by 260 papers, by iCite.

Cite this record

ConductScience Library. Fighting cancer by attacking its blood supply. Papers, record 8701285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8701285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fighting cancer by attacking its blood supply.
PubMed
Journal
Sci Am
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
260
iCite
Relative citation ratio, by iCite
6.61
iCite
Revised in PubMed
2022-03-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Folkman JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Angiostatins
Animals
Humans
Integrins
Neovascularization, Pathologic
Peptide Fragments
Plasminogen

Source PubMed

Download CSV of topics

Cited by65

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.

PMIDTitleJournalYearIn PapersSource
41090720A Change of Hallmark: An Update.Cells2025https://conductscience.org/library/papers/41090720PubMed
37315950Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.Adv Healthc Mater2023https://conductscience.org/library/papers/37315950PubMed
36944946Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.J Nanobiotechnology2023https://conductscience.org/library/papers/36944946PubMed
36214865Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.Naunyn Schmiedebergs Arch Pharmacol2023https://conductscience.org/library/papers/36214865PubMed
35514508Study of pro-angiogenic activity of astilbin on human umbilical vein endothelial cells in vitro and zebrafish in vivo.RSC Adv2019https://conductscience.org/library/papers/35514508PubMed
34638895β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models.Int J Mol Sci2021https://conductscience.org/library/papers/34638895PubMed
34440575Effect of HIT Components on the Development of Breast Cancer Cells.Life (Basel)2021https://conductscience.org/library/papers/34440575PubMed
34046500Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers.Biomed Res Int2021https://conductscience.org/library/papers/34046500PubMed
32751394So Uncommon and so Singular, but Underexplored: An Updated Overview on Ethnobotanical Uses, Biological Properties and Phytoconstituents of Sardinian Endemic Plants.Plants (Basel)2020https://conductscience.org/library/papers/32751394PubMed
32714772In Vivo Optofluidic Switch for Controlling Blood Microflow.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32714772PubMed
32528867Susceptibility and Resistance Mechanisms During Photodynamic Therapy of Melanoma.Front Oncol2020https://conductscience.org/library/papers/32528867PubMed
31919853Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer.Photochem Photobiol2020https://conductscience.org/library/papers/31919853PubMed
31878127Antitumor Potential and Phytochemical Profile of Plants from Sardinia (Italy), a Hotspot for Biodiversity in the Mediterranean Basin.Plants (Basel)2019https://conductscience.org/library/papers/31878127PubMed
31558974Tumor progression-dependent angiogenesis in gastric cancer and its potential application.World J Gastrointest Oncol2019https://conductscience.org/library/papers/31558974PubMed
31360737Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level.Oncoscience2019https://conductscience.org/library/papers/31360737PubMed
30323672Monitoring of tumor vascular normalization: the key points from basic research to clinical application.Cancer Manag Res2018https://conductscience.org/library/papers/30323672PubMed
29750999Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature.J Theor Biol2018https://conductscience.org/library/papers/29750999PubMed
29039610Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.Oncol Rep2017https://conductscience.org/library/papers/29039610PubMed
28808589Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.J Adv Res2017https://conductscience.org/library/papers/28808589PubMed
28683823Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice.BMC Pharmacol Toxicol2017https://conductscience.org/library/papers/28683823PubMed

See all 65 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8701285

GET https://conductscience.org/api/papers/v1/8701285/cited_by?page=2